Panomifene

From WikiMD's Food, Medicine & Wellnesspedia

Panomifene skeletal.svg


Panomifene (INN) (former developmental code names GYKI-13504, EGIS-5650) is a nonsteroidal selective estrogen receptor modulator (SERM) of the triphenylethylene group related to tamoxifen that was under development as an antineoplastic agent by Egis Pharmaceuticals and IVAX Drug Research Institute in the 1990s for the treatment of breast cancer but was not marketed.[1][2][3][4][5][6] It reached phase II clinical trials before development was terminated.[2] The drug was described in 1981.[1]

References[edit | edit source]

  1. ↑ 1.0 1.1
  2. ↑ 2.0 2.1 http://adisinsight.springer.com/drugs/800002425
  3. ↑
  4. ↑
  5. ↑
  6. ↑

External links[edit | edit source]



Panomifene Resources
Doctor showing form.jpg
Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.


Retrieved from "https://wikimd.com/w/index.php?title=Panomifene&oldid=5274443"

Contributors: Prab R. Tumpati, MD